TransMedics, Inc.’s cover photo
TransMedics, Inc.

TransMedics, Inc.

Medical Equipment Manufacturing

Andover, MA 16,938 followers

Redefining what's possible in organ transplantation

About us

Every Organ Wasted is a Life Not Saved. TransMedics, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for patients worldwide. Our mission is to help save more patients’ lives by increasing access to viable donor organs for those who are awaiting an organ transplant. To accomplish this mission, we partner closely with transplant stakeholders worldwide and help expand their access to healthy donor organs, while delivering the highest quality technology, service, and clinical care. With more than 25 years of commitment to excellence and innovation, TransMedics is at the forefront of advancing the field of organ transplantation. Our innovative Organ Care System (OCS™) technology is the only FDA-approved technology for lung, heart and liver transplant indications in the U.S., enabling the optimization and assessment of donor organs outside the human body and replacing a decades-old outdated standard of care: static cold storage (ice). Combined with our National OCS Program (NOP), a nationwide team of clinical experts, 24/7 logistics support, and the first-of-its-kind dedicated air & ground transport logistics network, we are enabling transplant centers to expand their search criteria for viable organ donors and grow overall transplant volumes in the U.S. www.TransMedics.com

Industry
Medical Equipment Manufacturing
Company size
501-1,000 employees
Headquarters
Andover, MA
Type
Public Company
Founded
1998

Locations

Employees at TransMedics, Inc.

Updates

  • 🚨 Join us for a Lunch Symposium during ISHLT 🚨 We’re excited to invite you to our upcoming session at ISHLT: 🫀 TransMedics Organ Care System (OCSTM) Next-Generation Clinical Innovations in Heart and Lung Transplantation 📅 Monday, April 28th 🕚 11:45 AM – 12:45 PM 📍 Ballroom B, Hynes Convention Center, Boston This symposium will feature leading transplant experts discussing cutting-edge advances in heart and lung transplantation—including next-gen clinical programs and real-world excellent clinical outcomes driven by TransMedics OCS NOP program.

    • No alternative text description for this image
  • We are thrilled to have ISHLT 2025 in Boston. We are looking forward to sharing our next-gen heart and lung clinical programs planned to start later this year! See you all at our annual Sysnposium on Monday!

    View organization page for TransMedics, Inc.

    16,938 followers

    🚨 We're heading to ISHLT 2025 in Boston! 🚨 TransMedics is proud to be a pinnacle sponsor of the Annual Meeting of International Society for Heart and Lung Transplantation (ISHLT), taking place in our hometown of Boston, MA. 🚨 Join us for a Lunch Symposium during ISHLT 🚨 We’re excited to invite you to our upcoming session at ISHLT: 🫀 TransMedics Organ Care System (OCSTM) Next-Generation Clinical Innovations in Heart and Lung Transplantation
 📅 Monday, April 28th
 🕚 11:45 AM – 12:45 PM
 📍 Ballroom B, Hynes Convention Center, Boston This symposium will feature leading transplant experts discussing cutting-edge advances in heart and lung transplantation—including next-gen clinical programs and real-world excellent clinical outcomes driven by TransMedics OCS NOP program.

    • No alternative text description for this image
  • 🚨 We're heading to ISHLT 2025 in Boston! 🚨 TransMedics is proud to be a pinnacle sponsor of the Annual Meeting of International Society for Heart and Lung Transplantation (ISHLT), taking place in our hometown of Boston, MA. 🚨 Join us for a Lunch Symposium during ISHLT 🚨 We’re excited to invite you to our upcoming session at ISHLT: 🫀 TransMedics Organ Care System (OCSTM) Next-Generation Clinical Innovations in Heart and Lung Transplantation
 📅 Monday, April 28th
 🕚 11:45 AM – 12:45 PM
 📍 Ballroom B, Hynes Convention Center, Boston This symposium will feature leading transplant experts discussing cutting-edge advances in heart and lung transplantation—including next-gen clinical programs and real-world excellent clinical outcomes driven by TransMedics OCS NOP program.

    • No alternative text description for this image
  • TransMedics, Inc. reposted this

    View profile for Waleed Hassanein, MD

    President & CEO, TransMedics Inc.

    Last week we held a press conference to announce our plans to open a state-of-the art innovation center and a second disposables manufacturing hub in Mirandola Italy. Mirandola is extremely rich with medical perfusion expertise and talent. This soldfies our commitment to continue to drive innovation in our field, while minimizing supply chain risks and build a solid foundation to ensure uninterrupted supply of our life-saving OCS Technology. We are just getting started. We cannot wait to share with the field our Gen-3 OCS Technology and our OCS Kidney platform! We do things few thought possible in Transplant medicine!

  • TransMedics, Inc. reposted this

    View profile for Waleed Hassanein, MD

    President & CEO, TransMedics Inc.

    In Rome for the day to participate in the Press Conference near the Italian Parliament to support the national reimbursement initiative for the OCS technology in Italy. We are grateful to the Italian patient organization and the Italian heart, lung and liver transplant academic experts who are leading this important initiative. The future looks promising for OCS, not just in Italy but also across Europe in the upcoming years. The collaborative efforts of various stakeholders pave the way for advancements in medical technology and patient care. OCS NOP in EU will become a reality very soon! #OCS #Transmedics #transplants #EUOCSNOP

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +1
  • TransMedics, Inc. reposted this

    View profile for Waleed Hassanein, MD

    President & CEO, TransMedics Inc.

    This week, over 175 transplant experts gathered for the transplant leadership forum focusing on lung, heart, and liver transplants. The event highlighted the Next-Gen OCS lung and heart clinical initiatives, along with an update on the first 4,500 OCS liver transplants in the US. The engagement and participation of clinical experts were greatly appreciated. Exciting advancements are on the horizon for 2025, as the Next-OCS is set to revolutionize the lung and heart transplant market. Stay tuned for the incredible developments ahead! OCS- Beyond Preservation! #transmedics #beyondpreservation #OCS

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • TransMedics, Inc. reposted this

    View profile for Waleed Hassanein, MD

    President & CEO, TransMedics Inc.

    TMDX was featured at Investors Business Daily. We are honored and humbled by our success to-date. We must remember that we are still early and we have a long runway of growth ahead to maximize the availability of healthy donor organs to help patients in need for organ transplants globally! TMDX team is working tirelessly to achieve this vision!

Similar pages

Browse jobs

Funding

TransMedics, Inc. 16 total rounds

Last Round

Post IPO debt

US$ 400.0M

See more info on crunchbase